海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
33件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Recruiting
- A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
- Alzheimer's Disease
- Argentina, Australia, Austria, Bulgaria, Canada, Czech Republic, Czechia, France, Germany, Greece, Japan, Korea, Republic of, Poland, Portugal, Romania, Russian Federation, Serbia, Slovakia, Spain, Sweden, United Kingdom, United States
- 2016-11-03
Recruiting
- COMBI-AD: A Phase III Randomized Double Blind Study of Dabrafenib (GSK2118436) in COMBInation With Trametinib (GSK1120212) Versus Two Placebos in the ADjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma After Surgical Resection
- Melanoma;C43 - Malignant melanoma of skin
- Argentina, Australia, Austria, Belgium, Canada, Czech Republic, Denmark, France, Germany, Greece, Israel, Italy, Netherlands, New Zealand, Norway, Russian Federation, Spain, Sweden, Switzerland, Taiwan, Province of China, United Kingdom, United States
- 2012-10-17
Recruiting
- BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
- Alzheimer Disease
- Austria, Canada, Finland, France, Germany, Greece, Hungary, Italy, Japan, Norway, Poland, Spain, United Kingdom, United States
- 2016-05-27
Recruiting
- A Phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability and pharmacokinetics (PK) of escalating single dose of brincidofovir administered intravenously in healthy adult subjects
- Adenovirus;cytomegalovirus;smallpox
- New Zealand
- 2016-12-01
Recruiting
- Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
- Pruritus;Prurigo Nodularis;Atopic Dermatitis;Psoriasis
- Austria, Germany, Poland, United States
- 2018-04-05
Recruiting
- Primary Immunodeficiencies impacting regulatory T cell biology
- ;E31.0 - Autoimmune polyglandular failure;D84 - Other immunodeficiencies;D82 - Immunodeficiency associated with other major defects;D89 - Other disorders involving the immune mechanism, not elsewhere classified
- Austria, Finland, France, Germany, Italy, Norway, Sweden, Switzerland, United Kingdom, United States
- 2019-06-05
Recruiting
- Clinical and Laboratory Online Patient- and Research Registry for Primary Immunodeficiencies of the European Society for Immunodeficiencies (ESID)
- ;D80 - Immunodeficiency with predominantly antibody defects;D81 - Combined immunodeficiencies;D82 - Immunodeficiency associated with other major defects;D83 - Common variable immunodeficiency;D84 - Other immunodeficiencies
- Austria, Belgium, Croatia, Czech Republic, Egypt, France, Germany, Hungary, Iran, Islamic Republic of, Ireland, Israel, Italy, Netherlands, Poland, Slovakia, Slovenia, Spain, Switzerland, United Kingdom
- 2015-02-05
Recruiting
- Non-Interventional Study on the Tolerability and Efficacy of IVIG
- Primary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIG
- Austria, Canada, France, Spain, United Kingdom
- 2014-11-20
Recruiting
- Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease
- Mild Cognitive Impairment;Alzheimer Disease;Healthy
- Austria
- 2015-12-21
Recruiting
- The German Itch Questionnaire, validation in different diagnoses
- urticaria, psoriasis, atopic eczema, patients with pruritus and kidney disease, patients with pruritus and liver disease, patients with pruritus and chronic prurigo, pruritus of multifactorial genesis, somatoform pruritus or neuropahtic pruritus;L29.8 - Other pruritus;L29.9 - Pruritus, unspecified;F45.8 - Other somatoform disorders
- Austria, Germany, Switzerland
- 2018-04-23
